Clinical Trial Update: Kansai Plus Atrial Fibrillation Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial for atrial fibrillation sponsored by Kyoto University has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Kyoto University, Graduate School of Medicine | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED